Article
In vitro data suggest a role for PMS2 Kozak sequence mutations in Lynch syndrome risk.
HGG advances - 18 Jul 2024
Matoy Evanjalina J, Plowman Jocelyn N, Watson Cynthia J, Belshan Michael A, Blue Elizabeth E, Huff Chad D, Stessman Holly A F
Abstract excerpt
Lynch syndrome (LS) is the most common hereditary cancer syndrome. Heterozygous loss-of-function variants in PMS2 are linked to LS. While these variants are not directly cancer causing, reduced PMS2 function results in the accumulation of somatic variants and increased cancer risk over time due to DNA mismatch repair dysfunction. It is reasonable that other types of genetic variation that impact the expression of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
